vs

Side-by-side financial comparison of Energy Services of America CORP (ESOA) and IONIS PHARMACEUTICALS INC (IONS). Click either name above to swap in a different company.

IONIS PHARMACEUTICALS INC is the larger business by last-quarter revenue ($203.3M vs $114.1M, roughly 1.8× Energy Services of America CORP). On growth, Energy Services of America CORP posted the faster year-over-year revenue change (13.4% vs -10.3%). Energy Services of America CORP produced more free cash flow last quarter ($16.8M vs $-159.0M). Over the past eight quarters, IONIS PHARMACEUTICALS INC's revenue compounded faster (30.4% CAGR vs 26.7%).

Superior Energy Services is an American oil services company that operates as a holding company for a portfolio of oilfield equipment rentals and well oil and gas services brands.

Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.

ESOA vs IONS — Head-to-Head

Bigger by revenue
IONS
IONS
1.8× larger
IONS
$203.3M
$114.1M
ESOA
Growing faster (revenue YoY)
ESOA
ESOA
+23.6% gap
ESOA
13.4%
-10.3%
IONS
More free cash flow
ESOA
ESOA
$175.8M more FCF
ESOA
$16.8M
$-159.0M
IONS
Faster 2-yr revenue CAGR
IONS
IONS
Annualised
IONS
30.4%
26.7%
ESOA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ESOA
ESOA
IONS
IONS
Revenue
$114.1M
$203.3M
Net Profit
$-229.4M
Gross Margin
12.3%
96.1%
Operating Margin
4.3%
-105.5%
Net Margin
-112.8%
Revenue YoY
13.4%
-10.3%
Net Profit YoY
-119.8%
EPS (diluted)
$0.16
$-1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESOA
ESOA
IONS
IONS
Q4 25
$114.1M
$203.3M
Q3 25
$130.1M
$156.7M
Q2 25
$103.6M
$452.0M
Q1 25
$76.7M
$131.6M
Q4 24
$100.6M
$226.6M
Q3 24
$104.7M
$133.8M
Q2 24
$85.9M
$225.3M
Q1 24
$71.1M
$119.5M
Net Profit
ESOA
ESOA
IONS
IONS
Q4 25
$-229.4M
Q3 25
$-128.6M
Q2 25
$123.6M
Q1 25
$-146.9M
Q4 24
$-104.3M
Q3 24
$-140.5M
Q2 24
$-66.3M
Q1 24
$-142.8M
Gross Margin
ESOA
ESOA
IONS
IONS
Q4 25
12.3%
96.1%
Q3 25
12.6%
98.5%
Q2 25
11.6%
99.1%
Q1 25
0.1%
98.9%
Q4 24
10.2%
98.3%
Q3 24
16.8%
99.2%
Q2 24
17.8%
98.2%
Q1 24
8.8%
98.2%
Operating Margin
ESOA
ESOA
IONS
IONS
Q4 25
4.3%
-105.5%
Q3 25
5.8%
-102.2%
Q2 25
3.1%
30.9%
Q1 25
-10.6%
-111.6%
Q4 24
1.6%
-48.9%
Q3 24
8.4%
-111.1%
Q2 24
9.9%
-29.3%
Q1 24
-1.5%
-125.1%
Net Margin
ESOA
ESOA
IONS
IONS
Q4 25
-112.8%
Q3 25
-82.1%
Q2 25
27.3%
Q1 25
-111.6%
Q4 24
-46.1%
Q3 24
-105.0%
Q2 24
-29.4%
Q1 24
-119.5%
EPS (diluted)
ESOA
ESOA
IONS
IONS
Q4 25
$0.16
$-1.35
Q3 25
$0.26
$-0.80
Q2 25
$0.12
$0.70
Q1 25
$-0.41
$-0.93
Q4 24
$0.05
$-0.66
Q3 24
$0.40
$-0.95
Q2 24
$1.06
$-0.45
Q1 24
$-0.07
$-0.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESOA
ESOA
IONS
IONS
Cash + ST InvestmentsLiquidity on hand
$16.7M
$2.7B
Total DebtLower is stronger
$62.0M
$1.8B
Stockholders' EquityBook value
$60.6M
$489.1M
Total Assets
$201.0M
$3.5B
Debt / EquityLower = less leverage
1.02×
3.71×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESOA
ESOA
IONS
IONS
Q4 25
$16.7M
$2.7B
Q3 25
$12.2M
$2.2B
Q2 25
$15.3M
$2.3B
Q1 25
$9.9M
$2.1B
Q4 24
$20.3M
$2.3B
Q3 24
$12.9M
$2.5B
Q2 24
$14.5M
$2.1B
Q1 24
$12.1M
$2.2B
Total Debt
ESOA
ESOA
IONS
IONS
Q4 25
$62.0M
$1.8B
Q3 25
$72.2M
Q2 25
$59.1M
Q1 25
$50.7M
Q4 24
$59.6M
$1.3B
Q3 24
$33.9M
Q2 24
$31.9M
Q1 24
$45.7M
Stockholders' Equity
ESOA
ESOA
IONS
IONS
Q4 25
$60.6M
$489.1M
Q3 25
$59.2M
$618.0M
Q2 25
$54.4M
$631.7M
Q1 25
$53.7M
$475.7M
Q4 24
$61.0M
$588.4M
Q3 24
$58.7M
$662.5M
Q2 24
$52.0M
$263.7M
Q1 24
$34.6M
$296.5M
Total Assets
ESOA
ESOA
IONS
IONS
Q4 25
$201.0M
$3.5B
Q3 25
$215.2M
$3.0B
Q2 25
$189.1M
$3.0B
Q1 25
$170.2M
$2.8B
Q4 24
$192.1M
$3.0B
Q3 24
$158.2M
$3.1B
Q2 24
$148.8M
$2.7B
Q1 24
$136.1M
$2.8B
Debt / Equity
ESOA
ESOA
IONS
IONS
Q4 25
1.02×
3.71×
Q3 25
1.22×
Q2 25
1.09×
Q1 25
0.94×
Q4 24
0.98×
2.13×
Q3 24
0.58×
Q2 24
0.61×
Q1 24
1.32×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESOA
ESOA
IONS
IONS
Operating Cash FlowLast quarter
$18.8M
$-137.7M
Free Cash FlowOCF − Capex
$16.8M
$-159.0M
FCF MarginFCF / Revenue
14.7%
-78.2%
Capex IntensityCapex / Revenue
1.8%
10.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$3.1M
$-320.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESOA
ESOA
IONS
IONS
Q4 25
$18.8M
$-137.7M
Q3 25
$-9.3M
$-131.4M
Q2 25
$3.4M
$151.3M
Q1 25
$1.1M
$-150.8M
Q4 24
$8.9M
$-116.1M
Q3 24
$-847.5K
$-115.0M
Q2 24
$19.3M
$-119.9M
Q1 24
$-2.7M
$-149.9M
Free Cash Flow
ESOA
ESOA
IONS
IONS
Q4 25
$16.8M
$-159.0M
Q3 25
$-12.0M
$-136.7M
Q2 25
$-582.0K
$139.0M
Q1 25
$-1.1M
$-163.4M
Q4 24
$6.0M
$-141.6M
Q3 24
$-2.9M
$-124.0M
Q2 24
$16.3M
$-126.1M
Q1 24
$-4.9M
$-154.4M
FCF Margin
ESOA
ESOA
IONS
IONS
Q4 25
14.7%
-78.2%
Q3 25
-9.3%
-87.2%
Q2 25
-0.6%
30.8%
Q1 25
-1.4%
-124.1%
Q4 24
5.9%
-62.5%
Q3 24
-2.8%
-92.7%
Q2 24
18.9%
-56.0%
Q1 24
-6.9%
-129.2%
Capex Intensity
ESOA
ESOA
IONS
IONS
Q4 25
1.8%
10.5%
Q3 25
2.1%
3.4%
Q2 25
3.9%
2.7%
Q1 25
2.9%
9.6%
Q4 24
2.9%
11.3%
Q3 24
2.0%
6.8%
Q2 24
3.6%
2.8%
Q1 24
3.1%
3.8%
Cash Conversion
ESOA
ESOA
IONS
IONS
Q4 25
Q3 25
Q2 25
1.22×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESOA
ESOA

Electricals Mechanical And General$49.4M43%
Gas And Petroleum Transmission$24.1M21%
Cost Plus And TM Contracts$23.3M20%
Transferred At Point In Time$17.9M16%

IONS
IONS

Products$58.0M29%
Spinraza Royalties$54.0M27%
Collaborative Agreement Revenue$52.4M26%
Wainus Royalties$16.0M8%
Wainua Joint Development Revenue$9.6M5%
Other Commercial$7.6M4%
Other Royalties$5.7M3%

Related Comparisons